Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix and Caliper to Develop Automated Target Preparation Instrument

NEW YORK, Jan. 13 (GenomeWeb News) - Affymetrix and Caliper Technologies plan to co-develop automated target preparation instruments for Affy's microarray platforms, the companies said today.

 

The first instruments developed under the multi-year agreement are scheduled to come out later this year. Affymetrix, of Santa Clara, Calif., will market and distribute the systems, which Caliper will provide under an OEM agreement. Caliper, located in Hopkinton, Mass., will be responsible for installation, training, and repair.

 

Separately, Caliper Technologies said it will change its name to Caliper Life Sciences, effective Jan. 23.

 

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.